TECON BIOLOGY Co.LTD / Fundamentals
Income statement
- Net revenue
€2.18B - Cost of goods sold
€1.91B - Gross profit
€270.46M - SG&A expenses
€70.44M - R&D expenses
€19.22M - EBITDA
€110.25M - D&A
€616.15K - EBIT
€86.86M - Interest expenses
€20.90M - EBT
€89.32M - Tax expenses
€1.42M - Net income
€80.68M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€312.03M - Changes in working capital
€0.00 - Operating cash flow
€347.00M - Capex
€36.76M - Other investing cash flow
-€11.06M - Net investing cash flow
-€50.36M - Total cash dividends paid
-€55.51M - Issuance of common stock
€0.00 - Debt repayment
-€115.42M - Other financing cash flow
-€8.81M - Net financing cash flow
-€179.74M - Foreign exchange effects
€0.00 - Net change in cash
€12.87M - Cash at end of period
€340.04M - Free cash flow
€383.76M
Balance sheet
- Cash and cash equivalents
€359.86M - Cash and short-term investments
€364.17M - Total receivables
€111.49M - Inventory
€458.07M - Other current assets
€128.46M - Total current assets
€1.06B - Property, plant & equipment
€782.14M - Goodwill
€20.07M - Intangible assets
€45.27M - Long-term investments
€0.00 - Other non-current assets
€42.16M - Total non-current assets
€903.59M - Total assets
€1.97B - Accounts payable
€62.08M - Short-term debt
€248.72M - Other current liabilities
€356.58M - Total current liabilities
€670.93M - Long-term debt
€233.69M - Deferred tax liabilities
€2.12M - Other non-current liabilities
€776.76K - Total non-current liabilities
€253.58M - Total liabilities
€924.51M - Common stock
€165.23M - Retained earnings
€148.18M - Other equity
€0.00 - Total equity
€1.04B - Total liabilities and shareholders' equity
€1.97B
Company information
- Market capitalization
€1.01B - Employees
5.3K - Enterprise Value
€10.86B
Company ratios
- Gross margin
-
12.4% Even with peer group: 16.3% - EBITDA margin
-
5.1% Worse than peer group: 11.8% - EBIT margin
-
4.0% Even with peer group: 6.9% - EBT margin
-
4.1% Even with peer group: 7.0% - Net margin
-
3.7% Even with peer group: 5.4% - ROE
-
7.7% Even with peer group: 7.4% - ROA
-
4.1% Even with peer group: 3.7% - Asset turnover
-
111.0% Better than peer group: 104.3% - FCF margin
-
14.2% Better than peer group: -4.1% - FCF yield
30.9% - Efficiency ratio
94.9% - Net sales per employee
-
€411.09K - Net income per employee
-
€15.20K